Appeal court overturns UK puberty blockers ruling for under-16s
Tavistock and Portman NHS foundation trust wins challenge over case brought by Keira Bell last year
The court of appeal has overturned a controversial judgment that children under the age of 16 considering gender reassignment are unlikely to be mature enough to give informed consent to be prescribed puberty-blocking drugs.
Tavistock and Portman NHS foundation trust, which runs NHS England’s only gender identity development service for children, challenged a high court ruling last year in a case brought against the service by Keira Bell, a 24-year-old woman who began taking puberty blockers when she was 16 before detransitioning. The other applicant was the unnamed mother of a teenage autistic girl on the waiting list for treatment.
The three high court judges had also said the doctors of teenagers under 18 may need to consult the courts for authorisation for medical intervention. As a result of the decision, the Tavistock suspended new referrals for puberty blockers and cross-sex hormones for the under-16s.
The court of appeal’s judgment was published on Friday.
More details to follow…